A bispecific immunotoxin (IHPP) with a long half-life targeting HER2 and PDGFRβ exhibited improved efficacy against HER2-positive tumors in a mouse xenograft model
2020 · International Journal of Pharmaceutics · 9 citations
https://doi.org/10.1016/j.ijpharm.2020.120037